Literature DB >> 3541569

Adipose tissue as a source of hormones.

P K Siiteri.   

Abstract

Obesity is known to increase the risk for cancer of the reproductive tract in women. The mechanism underlying this association can be explained by increased estrogenic stimulus to estrogen-target tissues as the result of three factors. First, increased adrenal secretory activity makes more androgen precursors available for conversion to estrogen in peripheral tissues. Second, the efficiency of conversion of androstenedione (A) to estrone (E1), is elevated in obese subjects because adipose tissue is the major tissue site of conversion. Third, plasma levels of SHBG, which binds estradiol (E2), are depressed in obese subjects and greater than normal amounts of serum estradiol are therefore available to target tissues from the circulation. Recent studies have shown that the levels of estrogens and other steroid hormones in breast fluids are much higher than in serum, which may be the result of local synthesis or increased uptake from the circulation. No differences in estrogen levels of breast fluid have been found between normal women and those with breast disease. A possible explanation may be differences in the levels of estrogen antagonists, such as progesterone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3541569     DOI: 10.1093/ajcn/45.1.277

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  135 in total

1.  The privatization of risk.

Authors:  B Rockhill
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 2.  Enzymatic intracrine regulation of white adipose tissue.

Authors:  David DiSilvestro; Jennifer Petrosino; Ayat Aldoori; Emiliano Melgar-Bermudez; Alexandra Wells; Ouliana Ziouzenkova
Journal:  Horm Mol Biol Clin Investig       Date:  2014-07

Review 3.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

4.  Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.

Authors:  Vanessa W Lim; Jun Li; Yinhan Gong; Aizhen Jin; Jian-Min Yuan; Eu Leong Yong; Woon-Puay Koh
Journal:  Endocr Relat Cancer       Date:  2014-02-27       Impact factor: 5.678

5.  Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Authors:  A Heather Eliassen; Wendy Y Chen; Donna Spiegelman; Walter C Willett; David J Hunter; Susan E Hankinson
Journal:  Arch Intern Med       Date:  2009-01-26

6.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

7.  Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health Study.

Authors:  Mengmeng Du; Peter Kraft; A Heather Eliassen; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Int J Cancer       Date:  2013-11-29       Impact factor: 7.396

8.  Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.

Authors:  Louise A Brinton; Llewellyn Smith; Gretchen L Gierach; Ruth M Pfeiffer; Sarah J Nyante; Mark E Sherman; Yikyung Park; Albert R Hollenbeck; Cher M Dallal
Journal:  Cancer Causes Control       Date:  2014-05-09       Impact factor: 2.506

9.  Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women.

Authors:  S Tanaka; T Kuroda; M Saito; M Shiraki
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

10.  Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.

Authors:  Louise A Brinton; Britton Trabert; Garnet L Anderson; Roni T Falk; Ashley S Felix; Barbara J Fuhrman; Margery L Gass; Lewis H Kuller; Ruth M Pfeiffer; Thomas E Rohan; Howard D Strickler; Xia Xu; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.